UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000023585
Receipt No. R000027163
Scientific Title Analysis of molecules whose expression level are changed by hemodialysis in hemodialysis patients
Date of disclosure of the study information 2016/08/10
Last modified on 2016/08/10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Analysis of molecules whose expression level are changed by hemodialysis in hemodialysis patients
Acronym Analysis of molecules whose expression level are changed by hemodialysis
Scientific Title Analysis of molecules whose expression level are changed by hemodialysis in hemodialysis patients
Scientific Title:Acronym Analysis of molecules whose expression level are changed by hemodialysis
Region
Japan

Condition
Condition Hemodialysis patients
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To investigate moleclues whose expression lelvel are changed by hemodialysis in hemodialysis patients.
Basic objectives2 Others
Basic objectives -Others To detect moleclues whose expression lelvel are changed by hemodialysis in hemodialysis patients.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To investigate moleclues whose expression lelvel are changed by hemodialysis in hemodialysis patients.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The hemodialysis patients.
Key exclusion criteria The patinets who cannot understand informed consent.
Target sample size 300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yoshiyuki Morishita
Organization Saitama Medical Center, Jichi Medical University
Division name Division of Nephrology, Department of Integrated Medicine
Zip code
Address 1-847, Amanuma, Omiya-ku, Saitama-city, Saitama, 330-8503, Japan
TEL 0486472111
Email ymori@jichi.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yoshiyuki Morishita
Organization Saitama Medical Center, Jichi Medical University
Division name Division of Nephrology, Department of Integrated Medicine
Zip code
Address 1-847, Amanuma, Omiya-ku, Saitama-city, Saitama, 330-8503, Japan
TEL 0486472111
Homepage URL
Email ymori@jichi.ac.jp

Sponsor
Institute Jichi Medical University
Institute
Department

Funding Source
Organization Jichi Medical University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 10 Month 20 Day
Date of IRB
Anticipated trial start date
2015 Year 10 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The analysis molecules whose expression lelves are changed by hemodialysis.

Management information
Registered date
2016 Year 08 Month 10 Day
Last modified on
2016 Year 08 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027163

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.